Weiqiang Mo

机构：Shanghai University, Nantong University, Dongguan University of Technology, Affiliated Hospital of Nantong University, Jiaxing University, First Hospital of Jiaxing

发表论文 11 篇 · 总被引 64 次 · h-index 5

代表论文

• Baseline characteristics of patients in the Chinese Bronchiectasis Registry (BE-China): a multicentre prospective cohort study (2025 · The Lancet Respiratory Medicine · 被引 32)
• Observation of the curative effect of device-guided rehabilitation on respiratory function in stable patients with chronic obstructive pulmonary disease (2019 · Medicine · 被引 12)
• A phase 4 multicentre, 2×2 factorial randomised, double-blind, placebo-controlled trial to investigate the efficacy and safety of tobramycin inhalation solution forPseudomonas aeruginosaeradication in bronchiectasis: ERASE (2024 · ERJ Open Research · 被引 7)
• Circular RNAs Hsa_circ_101555 and Hsa_circ_008068 as Diagnostic Biomarkers for Early-Stage Lung Adenocarcinoma (2022 · International Journal of General Medicine · 被引 7)
• Detection of PD‑L1 expression and epithelial‑mesenchymal transition of circulating tumor cells in non‑small cell lung cancer (2024 · Experimental and Therapeutic Medicine · 被引 5)
• Comparative analysis of extreme precipitation simulations over China by CMIP6 and CMIP5 models: similarities, differences, and uncertainty assessment (2025 · Environmental Research Communications · 被引 1)